MedPath

Evaluation of the effect of Nano zataria multiflra antifungal supplement on patients with onychomycosis with saprophytic agent

Phase 2
Recruiting
Conditions
onychomycosis.
Tinea unguium
B35.1
Registration Number
IRCT20210611051539N3
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

All people over 18 years old with mild-moderate onychomycosis caused by filamentous fungi

Exclusion Criteria

Patients who have taken antifungal drugs during treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvment of fungal lesions in term of clinical and mycological criteria. Timepoint: before the intervention and 2,4 weeks after the treatment start. Method of measurement: Examining clinical symptoms such as inflammation, itching, scaling and examination in terms of direct smear and fungal culture in the interval of 2, 4 and 6 weeks.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath